DEUTSCHE BANK AG\ - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 40 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2021$0
-100.0%
35
-99.9%
0.00%
Q2 2021$239,000
-18.2%
55,995
-18.8%
0.00%
Q1 2021$292,000
+7.4%
68,918
-1.6%
0.00%
Q4 2020$272,000
+0.7%
70,011
+4.7%
0.00%
Q3 2020$270,000
+13.9%
66,897
+20.1%
0.00%
Q2 2020$237,000
+20.3%
55,685
+18.5%
0.00%
Q1 2020$197,000
+146.2%
46,996
+130.0%
0.00%
Q4 2019$80,000
+50.9%
20,435
+234.2%
0.00%
Q3 2019$53,000
-1.9%
6,114
+1.8%
0.00%
Q2 2019$54,000
-68.6%
6,007
-77.7%
0.00%
Q1 2019$172,000
-61.8%
26,962
-43.6%
0.00%
Q4 2018$450,000
-86.5%
47,803
-71.2%
0.00%
-100.0%
Q3 2018$3,335,000
+46.9%
165,781
+112.9%
0.00%0.0%
Q2 2018$2,271,000
-26.6%
77,882
-25.0%
0.00%0.0%
Q1 2018$3,092,000
+144.4%
103,889
+164.2%
0.00%0.0%
Q4 2017$1,265,000
-34.2%
39,318
-28.9%
0.00%0.0%
Q3 2017$1,922,000
-17.8%
55,291
-29.7%
0.00%
-50.0%
Q2 2017$2,339,000
+34.4%
78,607
+34.7%
0.00%
+100.0%
Q1 2017$1,740,000
+161.3%
58,352
+53.0%
0.00%0.0%
Q4 2016$666,000
-25.0%
38,133
+2.0%
0.00%0.0%
Q3 2016$888,000
+66.6%
37,389
+12.2%
0.00%
Q2 2016$533,000
-27.3%
33,327
-5.1%
0.00%
-100.0%
Q1 2016$733,000
-80.3%
35,101
-74.5%
0.00%
-66.7%
Q4 2015$3,720,000
-8.4%
137,802
-5.8%
0.00%0.0%
Q3 2015$4,062,000
+220.3%
146,303
+182.4%
0.00%
+200.0%
Q2 2015$1,268,000
+73.2%
51,809
+29.5%
0.00%
Q1 2015$732,000
+32.4%
40,000
+33.3%
0.00%
Q4 2014$553,000
+4153.8%
30,000
+1900.0%
0.00%
Q2 2014$13,000
+116.7%
1,500
+150.0%
0.00%
Q1 2014$6,0006000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2015
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders